Table 1 Summary characteristics of included studies
From: The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis
Author | Country | Published date | Type of study | Number of patients | Female(%) | Median age(years) | NTIS(%) | Thyrotoxicosis(%) | Hypothyroidism(%) | Isolated elevated FT4(%) | Isolated low FT4(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Ahhn J, et al. | Korea | 2021/3 | Cohort | 119 | 47.9 | 64.3 | 18.5 | 14.3 | 3.4 | - | - |
Hashemipour S, et al. | Iran | 2022/1 | Cross-sectional | 131 | 37.9 | 61 | 51.7 | 6.9 | 6.9 | 8.1 | - |
Lania A, et al. | Italy | 2020/10 | Cohort | 287 | 22.9 | 66 | - | 20.2 | 5.1 | - | - |
Lui DTW, et al. | China | 2021/6 | Cohort | 122 | 50.8 | 58 | 9.8 | 4 | 0.8 | 1.6 | |
Lui DTW, et al. | China | 2021/9 | Cohort | 367 | 53.1 | 54 | 7.4 | - | - | 1.3 | 0.5 |
Lui DTW, et al. | China | 2021/9 | Cohort | 204 | 53.4 | 55 | - | 6.3 | 1.4 | 0.98 | 0.98 |
Dabas, et al. | India | 2021/10 | Cross-sectional | 164 | 36.3 | 54 | 53.7 | - | 8.53 | - | 2.1 |
Chinmay, et al. | India | 2021/4 | Cohort | 251 | 36.5 | - | - | - | 1.53 | - | - |